Edit |   |
---|---|
Antigenic Specificity | CD33, Human (Lintuzumab biosimilar) |
Clone | Lintuzumab |
Host Species | Recombinant Mouse |
Reactive Species | human |
Isotype | IgG1 kappa |
Format | purified |
Size | 1mg, 5mg |
Concentration | 1mg/ml |
Applications | IF, IP, Neut, FuncS, ELISA, FCM, ICC |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | Anti-Human CD33 Recombinant Antibody (Lintuzumab). Lintuzumab (SGN-33) is a humanized monoclonal antibody used in the treatment of cancer. The drug had been developed by Seattle Genetics as a treatment for acute myeloid leukemia (AML), a condition which results in the deaths of 9, 000 people a year in the United States. |
Immunogen | n/a |
Other Names | Anti-CD33 Recombinant Antibody, Research Grade Lintuzumab, Anti-Human CD33 Recombinant Antibody(Lintuzumab), 225Ac-lintuzumab, Antibody Drug Analogues, Monoclonal Antibody, YR1025, Research Grade Biosimilars, Biosimilar Antibody |
Gene, Accession # | CAS: 166089-32-3 |
Catalog # | YR1025 |
Price | please inquire |
Order / More Info | CD33, Human (Lintuzumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD. |
Product Specific References | n/a |